Target intelligence / Profile preview

Clostridioides difficile toxin A combined repetitive oligopeptides domain (TcdA-CROP)

Target
TcdA-CROP
Molecular classification
Bacterial toxin, Lectin, Carbohydrate-binding protein
01

Overview

Clostridioides difficile toxin A (TcdA) is a major virulence factor responsible for the clinical manifestations of C. difficile infection (CDI), including diarrhea and colitis [1]. The C-terminal repeat domain, frequently termed the combined repetitive oligopeptides (CROPs) domain, is the region of the toxin responsible for binding to carbohydrate receptors on the surface of host intestinal epithelial cells [2]. This domain consists of multiple repetitive sequences that form a solenoid-like structure, facilitating multivalent binding to glycans such as the Lewis X and Y antigens [3]. Once the CROPs domain anchors the toxin to the cell membrane, the toxin is internalized via receptor-mediated endocytosis, leading to the glucosylation of host Rho GTPases and subsequent cell death [4]. Because this domain is essential for the initial step of toxin entry, it has become a primary target for therapeutic intervention, including neutralizing monoclonal antibodies like actoxumab and various vaccine candidates designed to elicit a protective immune response [5]. [1] UniProt P16154 (TCDA_CLODI). [2] Greco et al. (2006) PMID: 16412602. [3] Voth & Ballard (2005) PMID: 15659137. [4] Jank & Aktories (2013) PMID: 23595305. [5] Gerding et al. (2018) PMID: 29562316.

Other names
TcdA C-terminal repeat domainTcdA receptor-binding domainTcdA-CBDClostridium difficile toxin A C-terminal repeats
02

Mechanism of action

Neutralization of toxin binding to host cell surface receptors, thereby preventing toxin internalization and subsequent cellular damage.

03

Biological functions

Host cell bindingReceptor-mediated endocytosisToxin internalization
04

Disease associations

Clostridioides difficile infectionAntibiotic-associated diarrheaPseudomembranous colitis
05

Safety considerations

Infusion-related reactionsDevelopment of anti-drug antibodiesLimited efficacy against TcdA-negative/TcdB-positive strains
06

Interacting drugs

Actoxumab

2 more in the full profile.

07

Biomarkers

TcdA stool levelsSerum anti-TcdA antibody titers

Beyond the preview

Go deeper on Clostridioides difficile toxin A combined repetitive oligopeptides domain (TcdA-CROP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile toxin A combined repetitive oligopeptides domain (TcdA-CROP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call